Investment
Features
FeesSafety
Academy
More
Pluang+

WISeKey reports 62% revenue growth in 2025, strong cash position, and optimistic 2026 outlook with $200M+ pipeline.

Company Fundamentals
30 Apr 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

WISeKey International Holding Ltd reported a 62% revenue increase to $19.3 million for 2025, driven by growth in its semiconductor subsidiary SEALSQ, which grew 66%. The company ended 2025 with a strong cash position of $429 million, boosted to over $535 million by April 2026, enabling strategic investments and R&D in post-quantum technology. WISeKey expects 2026 revenue to grow 50%-100% year-over-year, supported by a commercial pipeline exceeding $200 million through 2029, including significant projects like QS7001 and QVault TPM. The company is advancing its quantum-secure semiconductor platform and plans to list its satellite subsidiary WISeSat.Space on Nasdaq in late 2026.

More News

Ipsen Pharma repurchases 28,541 shares at an average price of €166 in early July 2026

Ipsen Pharma repurchases 28,541 shares at an average price of €166 in early July 2026

Ipsen Pharma conducted share buybacks from July 6 to July 10, 2026, purchasing a total of 28,541 shares. The average purchase price was €166.05 per share. These buybacks were made under Article 5 of the MAR regulation, indicating a structured repurch...

Company Fundamentals
Neutral
13 minutes ago
Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays increased its price target for Hudbay Minerals to $32 from $30, citing strong growth prospects in copper mining. Despite a recent nearly 30% stock pullback due to market sentiment, Hudbay maintains a solid financial position with near-zero n...

Analyst Insights
Bullish
1 hour ago
Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley reported strong Q2 2026 results, with earnings per share of $3.46 surpassing estimates of $2.89 and revenue of $21.35 billion beating forecasts of $19.67 billion. This marks significant year-over-year growth from $16.79 billion, driven...

Company Fundamentals
Bullish
1 hour ago
Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...

Market News
Bullish
1 hour ago
Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...

Others
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App